London · Delayed Price · Currency is GBP · Price in GBX Creo Medical Group Statistics
Total Valuation
AIM:CREO has a market cap or net worth of GBP 47.63 million. The enterprise value is 44.13 million.
| Market Cap | 47.63M |
| Enterprise Value | 44.13M |
Important Dates
The next estimated earnings date is Wednesday, December 23, 2026.
| Earnings Date | Dec 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:CREO has 448.26 million shares outstanding. The number of shares has increased by 8.59% in one year.
| Current Share Class | 448.26M |
| Shares Outstanding | 448.26M |
| Shares Change (YoY) | +8.59% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.21% |
| Owned by Institutions (%) | 74.06% |
| Float | 409.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.80 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.79 |
| Quick Ratio | 2.33 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -43.75 |
Financial Efficiency
Return on equity (ROE) is -29.15% and return on invested capital (ROIC) is -39.15%.
| Return on Equity (ROE) | -29.15% |
| Return on Assets (ROA) | -17.42% |
| Return on Invested Capital (ROIC) | -39.15% |
| Return on Capital Employed (ROCE) | -35.71% |
| Weighted Average Cost of Capital (WACC) | 9.44% |
| Revenue Per Employee | 67,308 |
| Profits Per Employee | -193,269 |
| Employee Count | 104 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 1.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.87% in the last 52 weeks. The beta is 0.96, so AIM:CREO's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -7.87% |
| 50-Day Moving Average | 11.98 |
| 200-Day Moving Average | 13.05 |
| Relative Strength Index (RSI) | 37.27 |
| Average Volume (20 Days) | 1,165,179 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:CREO had revenue of GBP 7.00 million and -20.10 million in losses. Loss per share was -0.05.
| Revenue | 7.00M |
| Gross Profit | 2.90M |
| Operating Income | -17.50M |
| Pretax Income | -15.90M |
| Net Income | -20.10M |
| EBITDA | -16.90M |
| EBIT | -17.50M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 7.40 million in cash and 3.90 million in debt, with a net cash position of 3.50 million or 0.01 per share.
| Cash & Cash Equivalents | 7.40M |
| Total Debt | 3.90M |
| Net Cash | 3.50M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 48.20M |
| Book Value Per Share | 0.12 |
| Working Capital | 14.00M |
Cash Flow
In the last 12 months, operating cash flow was -21.80 million and capital expenditures 200,000, giving a free cash flow of -21.80 million.
| Operating Cash Flow | -21.80M |
| Capital Expenditures | 200,000 |
| Depreciation & Amortization | 600,000 |
| Net Borrowing | -200,000 |
| Free Cash Flow | -21.80M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 41.43%, with operating and profit margins of -250.00% and -287.14%.
| Gross Margin | 41.43% |
| Operating Margin | -250.00% |
| Pretax Margin | -227.14% |
| Profit Margin | -287.14% |
| EBITDA Margin | -241.43% |
| EBIT Margin | -250.00% |
| FCF Margin | n/a |
Dividends & Yields
AIM:CREO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.59% |
| Shareholder Yield | -8.59% |
| Earnings Yield | -42.20% |
| FCF Yield | -45.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AIM:CREO has an Altman Z-Score of -1.33 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.33 |
| Piotroski F-Score | 2 |